Contract 75D30122P13255
Fujirebio Us, Inc. · Department Of Health And Human Services · June 30, 2025
Fujirebio Us, Inc. was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on June 30, 2025 for an undisclosed amount of work in in-vitro diagnostic substance manufacturing. Performance is in Atlanta, GA. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- 75D30122P13255
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Atlanta, GA
- First action
- June 30, 2025
Description
FUJIREBIO DIAGNOSTICS LAB SUPPLY
Modification timeline
-
June 30, 2025Mod P00001 · Other Administrative Action$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30122P13255?
Contract 75D30122P13255 is a federal contract awarded to Fujirebio Us, Inc. by Department Of Health And Human Services on June 30, 2025 for an undisclosed amount of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75D30122P13255?
Fujirebio Us, Inc. won contract 75D30122P13255 from Department Of Health And Human Services.
How much is contract 75D30122P13255 worth?
Contract 75D30122P13255 has no obligated funds in the available record. It may be a pre-award placeholder or an indefinite-delivery vehicle awaiting task orders.